EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Brain Organoids: A Game-Changer for Drug Testing

Chiara Giorgi iD, Giorgia Lombardozzi iD, Fabrizio Ammannito, Marta Sofia Scenna iD, Eleonora Maceroni iD, Massimiliano Quintiliani, Michele d'Angelo iD, Annamaria Cimini iD, Vanessa Castelli iD

Pharmaceutics · 22.03.2024 · 16 (4) · 443

DOI: 10.3390/pharmaceutics16040443 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 22.03.2024. Verfasst von Chiara Giorgi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life, Health and Environmental Science, University of L'Aquila, 67100 L'Aquila, Italy. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, Ministry of Enterprises and Made in Italy, European Union-NextGenerationEU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurological disorders are the second cause of death and the leading cause of disability worldwide. Unfortunately, no cure exists for these disorders, but the actual therapies are only able to ameliorate people’s quality of life. Thus, there is an urgent need to test potential therapeutic approaches. Brain organoids are a possible valuable tool in the study of the brain, due to their ability to reproduce different brain regions and maturation stages; they can be used also as a tool for disease modelling and target identification of neurological disorders. Recently, brain organoids have been used in drug-screening processes, even if there are several limitations to overcome. This review focuses on the description of brain organoid development and drug-screening processes, discussing the advantages, challenges, and limitations of the use of organoids in modeling neurological diseases. We also highlighted the potential of testing novel therapeutic approaches. Finally, we examine the challenges and future directions to improve the drug-screening process.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer’s diseaseCreutzfeldt–Jakob diseaseNiemann Pick diseasebraindrugdrug screeninggliomaneurological disorderstherapeutic approaches

Autor:innen und Institutionen

  • Department of Life, Health and Environmental Science, University of L'Aquila, 67100 L'Aquila, Italy.

ORCID-Profile: Chiara Giorgi, Giorgia Lombardozzi, Marta Sofia Scenna, Eleonora Maceroni, Michele d'Angelo, Annamaria Cimini, Vanessa Castelli

Förderung

  • European Union
  • Ministry of Enterprises and Made in Italy
  • European Union-NextGenerationEU
  • Ministry of Enterprises

Zitieren

APA

Giorgi, C., Lombardozzi, G., Ammannito, F., Scenna, M. S., Maceroni, E., Quintiliani, M., d'Angelo, M., Cimini, A., & Castelli, V. (2024). Brain Organoids: A Game-Changer for Drug Testing. Pharmaceutics, 16(4), 443. https://doi.org/10.3390/pharmaceutics16040443

Vancouver

Giorgi C, Lombardozzi G, Ammannito F, Scenna MS, Maceroni E, Quintiliani M, et al. Brain Organoids: A Game-Changer for Drug Testing. Pharmaceutics. 2024;16(4):443. doi:10.3390/pharmaceutics16040443

BibTeX
@article{Giorgi2024,
  author = {Giorgi, Chiara and Lombardozzi, Giorgia and Ammannito, Fabrizio and Scenna, Marta Sofia and Maceroni, Eleonora and Quintiliani, Massimiliano and d'Angelo, Michele and Cimini, Annamaria and Castelli, Vanessa},
  title = {Brain Organoids: A Game-Changer for Drug Testing},
  journal = {Pharmaceutics},
  year = {2024},
  volume = {16},
  number = {4},
  pages = {443},
  doi = {10.3390/pharmaceutics16040443}
}
Kostenlos starten →